|
Monday January 8, 3:19 am Eastern Time Roche, Millennium in arthritis diagnostics venture (UPDATE: Adds comment from statement, market reaction) BASEL, Switzerland, Jan 8 (Reuters) - Roche Holding AG`s Roche Diagnostics division has struck an alliance with Millennium Pharmaceuticals Inc (NasdaqNM:MLNM - news) to develop diagnostic products for rheumatoid arthritis, Roche said on Monday. U.S.-based Millennium will receive a licensing fee, funding for research and milestone payments and royalties under the three-year deal. Roche gets certain research and development rights for select diagnostic markers in this disease area. It will also market products resulting from the alliance, it said without giving financial details. Roche certificates opened up 75 Swiss francs at 16,120 in a generally firmer Swiss market. ``The combination of Roche`s world-class strength in diagnostics with Millennium`s strong position in genomics and proteomics will bring revolutionary diagnostic products to market,`` said Heino von Prondzynski, the head of Roche`s diagnostics division. |
|
| aus der Diskussion: | Millennium Pharma.+ Roche AG |
| Autor (Datum des Eintrages): | dakinky (08.01.01 11:58:25) |
| Beitrag: | 1 von 2 (ID:2651087) |
| Alle Angaben ohne Gewähr © wallstreetONLINE | |